597 filings
10-Q
2024 Q1
GYRE
Gyre Therapeutics Inc
Quarterly report
13 May 24
4:07pm
8-K
GYRE
Gyre Therapeutics Inc
9 May 24
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:05pm
8-K
GYRE
Gyre Therapeutics Inc
8 May 24
Regulation FD Disclosure
8:00am
ARS
2023 FY
GYRE
Gyre Therapeutics Inc
29 Apr 24
Annual report to shareholders
8:49am
DEFA14A
GYRE
Gyre Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
8:48am
S-8
bvajbhx
27 Mar 24
Registration of securities for employees
9:00pm
8-K
ib80x22pdc3mzblynxw
26 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
xa7nik5jpi
25 Mar 24
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
9:55pm
8-K
rgx4kdjx9skb
21 Mar 24
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
7:15am
8-K
rzzm26kkpom
14 Feb 24
Results of Operations and Financial Condition
5:16pm
8-K/A
gqxg91yn1j9g9e0oozfl
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K/A
jr9yvrg73mpo nvfiu
12 Jan 24
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
l51w 81f6clh28
15 Dec 23
Departure of Directors or Certain Officers
4:21pm
8-K
3073w q9uqn9
6 Dec 23
Regulation FD Disclosure
4:01pm
RW
uebz5xsr7 hjvero7kz9
29 Nov 23
Registration withdrawal request
4:01pm
8-K
hdq99iii98
14 Nov 23
Regulation FD Disclosure
12:00am
D
jj3fwnnu ld9tcyvdu
13 Nov 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:13pm